A closer look at “PhRMA Sues Trump Administration Over Medicare Drug Pricing Pilot Tied to Foreign Prices”, exactly as the source publishes it. The Pharmaceutical Research and Manufacturers of America (PhRMA), the leading trade group for brand-name drugmakers, has filed a lawsuit against the Trump administration over a new Medicare pilot program. drug prices to lower prices paid in peer countries, a move the industry argues is unlawful and harmful to innovation. The lawsuit, filed in federal court, challenges the legal authority of the Centers for Medicare & Medicaid Services to implement the model, which PhRMA says would import foreign price controls and reduce access to medicines for seniors.
The Trump administration has defended the plan as a way to lower out-of-pocket costs for Medicare beneficiaries and save taxpayers billions. The case marks a significant escalation in the long-running battle over drug pricing, with implications for the pharmaceutical industry, patients, and the 2020 election. For the complete material, the listing points back to the source inside the network.